This article needs additional citations for verification .(March 2018) |
Compound | Comments | In whole blood (g/cm3) | In plasma or serum (g/cm3) |
---|---|---|---|
Water | Solvent | 0.81-0.86 | 0.93-0.95 |
Acetoacetate | Produced in liver | 8-40 ×10−7 | 4-43 ×10−7 |
Acetone | product of bodyfat breakdown | 3-20 ×10−6 | |
Acetylcholine | Neurotransmitter of the parasympathetic nervous system | 6.6-8.2 ×10−8 | |
Adenosine triphosphate | Energy storage | ||
total | 3.1-5.7 ×10−4 | ||
phosphorus | 5-10 ×10−5 | ||
Adrenocorticotrophic hormone | Stimulates the adrenal cortex | 2.5-12 ×10−11 | |
@ 6AM, mean | 5.5 ×10−11 | ||
@ 6AM, maximum | 12 ×10−11 | ||
@ 6PM, mean | 3.5 ×10−11 | ||
@ 6PM, maximum | <7.5 ×10−11 | ||
Alanine | Amino acid | 2.7-5.5 ×10−5 | 2.4-7.6 ×10−5 |
Albumin | Blood plasma protein | 3.5-5.0 ×10−2 [1] | |
Aluminum | 1-40 ×10−8 | 1-88 ×10−8 | |
Selenium | 60–150 ng/mL | ||
Aldosterone | Regulates electrolyte balance | ||
supine | 3-10 ×10−11 | ||
standing, male | 6-22 ×10−11 | ||
standing, female | 5-30 ×10−11 | ||
Amino acids | Protein building blocks | ||
total | 3.8-5.3 ×10−4 | ||
nitrogen | 4.6-6.8 ×10−5 | 3.0-5.5 ×10−5 | |
alpha-Aminobutyric acid | 1-2 ×10−6 | 1-2 ×10−6 | |
δ-Aminolevulinic acid | 1.5-2.3 ×10−7 | ||
Ammonia nitrogen | 1-2 ×10−6 | 1.0-4.9 ×10−7 | |
cAMP | Intracellular signal transduction molecule | ||
male | 5.6-10.9 ×10−9 | ||
female | 3.6-8.9 ×10−9 | ||
Androstenedione | Steroid hormone | ||
male >18 yrs | 2-30 ×10−10 | ||
female >18 yrs | 8-30 ×10−10 | ||
Androsterone | Steroid hormone | 1.5 ×10−7 | |
Angiotensin I | Angiotensin II precursor | 1.1-8.8 ×10−11 | |
Angiotensin II | Vasoconstrictor | 1.2-3.6 ×10−11 | |
Alpha 1-antitrypsin | Serine protease inhibitor | 7.8-20 ×10−4 | |
Arginine | Amino acid | 6-17 ×10−6 | 1.3-3.6 ×10−5 |
Arsenic | normal range | 2-62 ×10−9 | |
chronic poisoning | 100-500 ×10−9 | ||
acute poisoning | 600-9300 ×10−9 | ||
Ascorbic acid (Vitamin C) | Important vitamin | 1-15 ×10−6 | 6-20 ×10−6 |
Aspartic acid | Amino acid | 0-3 ×10−6 | |
In WBCs | 2.5-4.0 ×10−4 | 9-12 ×10−6 | |
Bicarbonate | Buffer in blood | 5-5.7 ×10−4 | |
Bile acids | Digestive function, bilirubin excretion | 2-30 ×10−6 | 3-30 ×10−6 |
Bilirubin | Hemoglobin metabolite | 2-14 ×10−6 | 1-10 ×10−6 |
Biotin (Vitamin H) | Gluconeogenesis, metabolize leucine, fatty acid synthesis | 7-17 ×10−9 | 9-16 ×10−9 |
Blood Urea Nitrogen (BUN) | 8-23 ×10−5 | ||
Bradykinin | 7 ×10−11 | ||
Bromide | 7-10 ×10−9 | ||
Cadmium | normal | 1-5 ×10−9 | |
toxic | 0.1-3 ×10−6 | ||
Calciferol (vitamin D2) | Maintain calcium and phosphorus levels | 1.7-4.1 ×10−8 | |
Calcitonin (CT) | Hormone | <1.0 ×10−10 | |
Calcium | Bones, Ca2+ | ||
ionized | 4.48-4.92 ×10−5 | 4.25-5.25 ×10−5 | |
total | 8.4-11.5 ×10−5 | ||
Carbon dioxide | Respiratory gas | ||
arterial | 8.8-10.8 ×10−4 | 3.0-7.9 ×10−5 | |
venous | 9.8-11.8 ×10−4 | 3.3-8.3 ×10−5 | |
Carboxyhemoglobin(as HbCO) | nonsmokers | 0.5-1.5% total Hb | |
smokers, 1-2 packs/day | 4-5% total Hb | ||
smokers, 2 packs/day | 8-9% total Hb | ||
toxic | >20% total Hb | ||
lethal | >50% total Hb | ||
Carcinoembryonic antigen | <2.5 ×10−9 | ||
beta-Carotene | Vitamin A dimer | 3-25 ×10−7 | |
Carotenoids | Antioxidant | 2.4-23.1 ×10−7 | |
Cephalin | 3-11.5 ×10−4 | 0-1 ×10−4 | |
Ceruloplasmin | 1.5-6 ×10−4 | ||
Chloride, as NaCl | 4.5-5 ×10−3 | 3.5-3.8 ×10−3 | |
Cholecalciferol (Vitamin D3) | 1, 25-dihydroxy | 2.5-4.5 ×10−11 | |
24,25-dihydroxy | 1.5 ×10−9 | ||
25-hydroxy | 1.4-8 ×10−8 | ||
Cholecystokinin (pancreozymin) | Stimulates fat and protein digestion | 6.04 ×10−11 | |
Cholesterol | Steroid lipid | ||
LDLC | 0.5-2.0 ×10−3 | ||
HDLC | 2.9-9.0 ×10−4 | ||
total | 1.15-2.25 ×10−3 | 1.2-2 ×10−3 | |
Choline, total | 1.1-3.1 ×10−4 | 3.6-3.5 ×10−4 | |
Chorionic gonadotropin | Progesterone secretion during pregnancy | ||
Menstrual | 0-3 ×10−11 | ||
Pregnancy, 1st trimester | 5-3300 ×10−10 | ||
Pregnancy, 2nd trimester | 20-1000 ×10−10 | ||
Pregnancy, 3rd trimester | 20-50 ×10−10 | ||
Menopausal | 3-30 ×10−11 | ||
Citric acid | 1.3-2.5 ×10−5 | 1.6-3.2 ×10−5 | |
Citrulline | 2-10 ×10−6 | ||
Coagulation Factors | Fibrinogen | 1.2-1.6 ×10−3 | 2-4 ×10−3 |
Prothrombin | 1 ×10−4 | ||
Tissue thromboplastin | 1 ×10−6 | ||
Proaccelerin | 5-12 ×10−6 | ||
Proconvertin | 1 ×10−6 | ||
Antihemophilic factor | 1 ×10−7 | ||
Christmas factor | 4 ×10−6 | ||
Stuart factor | 5 ×10−6 | ||
Plasma thrmb. anteced. | 4 ×10−6 | ||
Hageman factor | 2.9 ×10−5 | ||
Fibrin-stabilizing factor | 1 ×10−5 | ||
Fibrin split products | <1 ×10−5 | ||
Fletcher factor | 5 ×10−5 | ||
Fitzgerald factor | 7 ×10−5 | ||
von Willebrand factor | 7 ×10−6 | ||
Cobalamin (Vitamin B12) | Needed for nerve cells, red blood cells, and to make DNA | 6-14 ×10−10 | 1-10 ×10−10 |
Cocarboxylase | 7-9 ×10−8 | ||
Complement system | C1q | 5.8-7.2 ×10−5 | |
C1r | 2.5-3.8 ×10−5 | ||
C1s (C1 esterase) | 2.5-3.8 ×10−5 | ||
C2 | 2.2-3.4 ×10−5 | ||
C3( b1C-globulin) | 8-15.5 ×10−4 | ||
factor B (C3 proactivator) | 2-4.5 ×10−4 | ||
C4 (b1E-globulin) | 1.3-3.7 ×10−4 | ||
C4 binding protein | 1.8-3.2 ×10−4 | ||
C5 (b1F-globulin) | 5.1-7.7 ×10−5 | ||
C6 | 4.8-6.4 ×10−5 | ||
C7 | 4.9-7 ×10−5 | ||
C8 | 4.3-6.3 ×10−5 | ||
C9 | 4.7-6.9 ×10−5 | ||
Properdin | 2.4-3.2 ×10−5 | ||
Compound S | 1-3 ×10−9 | ||
Copper | 9-15 ×10−7 | ||
male | 7-14 ×10−7 | ||
female | 8-15.5 ×10−7 | ||
Corticosteroids | Steroid hormones | 1-4 ×10−6 | |
Corticosterone | 4-20 ×10−9 | ||
Cortisol | Inhibits CRH secretion | 3-23 ×10−8 | |
8 AM | 6-23 ×10−8 | ||
4 PM | 3-15 ×10−8 | ||
10 PM | ~50% of 8 AM value | ||
C-peptide | fasting | 0.5-2.0 ×10−9 | |
maximum | 4 ×10−9 | ||
C-reactive protein | Plasma protein | 6.8-820 ×10−8 | |
Creatine | Assists muscle cell energy supply | ||
male | 1.7-5.0 ×10−6 | ||
female | 3.5-9.3 ×10−6 | ||
Creatinine | male | 0.8-1.5 ×10−5 | |
female | 0.7-1.2 ×10−5 | ||
Cyanide | nonsmokers | 4 ×10−9 | |
smokers | 6 ×10−9 | ||
nitroprusside therapy | 10-60 ×10−9 | ||
toxic | >100 ×10−9 | ||
lethal | >1000 ×10−9 | ||
Cysteine | Amino acid | 6-12 ×10−6 | 1.8-5 ×10−5 |
Dehydroepiandrosterone(DHEA) | Steroid hormone | ||
aged 1–4 yrs | 0.2-0.4 ×10−9 | ||
aged 4–8 yrs | 0.1-1.9 ×10−9 | ||
aged 8–10 yrs | 0.2-2.9 ×10−9 | ||
aged 10–12 yrs | 0.5-9.2 ×10−9 | ||
aged 12–14 yrs | 0.9-20 ×10−9 | ||
aged 14–16 yrs | 2.5-20 ×10−9 | ||
male | 0.8-10 ×10−9 | ||
female, premenopausal | 2.0-15 ×10−9 | ||
DHEA sulfate | male | 1.99-3.34 ×10−6 | |
female | |||
newborn | 1.67-3.64 ×10−6 | ||
pre-pubertal children | 1.0-6.0 ×10−7 | ||
premenopausal | 8.2-33.8 ×10−7 | ||
pregnancy | 2.3-11.7 ×10−7 | ||
postmenopausal | 1.1-6.1 ×10−7 | ||
11-Deoxycortisol | 1-7 ×10−8 | ||
Dihydrotestosterone (DHT) | male | 3-8 ×10−9 | |
female | 1-10 ×10−10 | ||
Diphosphoglycerate (phosphate) | 8-16 ×10−5 | ||
DNA | The molecule of heredity | 0-1.6 ×10−5 | |
Dopamine | Neurotransmitter | <1.36 ×10−10 | |
Enzymes, total | <6 ×10−5 | ||
Epidermal growth factor (EGF) | <1 ×10−11 | ||
Epinephrine | Neurotransmitter of the sympathetic nervous system | ||
after 15 min rest | 3.1-9.5 ×10−11 | ||
when emitted | 3.8 ×10−9 | 2-2.5 ×10−9 | |
Ergothioneine | 1-20 ×10−5 | ||
Erythrocytes (#/cm3) | adult male, avg. (range) | 5.2 (4.6-6.2) ×109 | |
adult female, avg. (range) | 4.6 (4.2-5.4) ×109 | ||
children, varies with age | 4.5-5.1 ×109 | ||
reticulocytes | 25-75 ×106 | ||
Erythropoietin | adult, normal | 0.5-2.5 ×10−10 | |
pregnant | 2.7-6.2 ×10−10 | ||
hypoxia or anemia | 0.8-8.0 ×10−8 | ||
Estradiol (E2) | male | 8-36 ×10−12 | |
female, follicular(days 1-10) | 1-9 ×10−11 | ||
female, mean | 5 ×10−11 | ||
female, pre-fertile (days 10-12) | 10-15 ×10−11 | ||
female, fertile (days 12-14) | 35-60 ×10−11 | ||
female, luteal (days 15-28) | 20-40 ×10−11 | ||
female, pregnancy | 3-70 ×10−7 | ||
female, postmenopausal | 1-3 ×10−11 | ||
Estriol (E3) | nonpregnant | <2 ×10−9 | |
pregnancy, weeks 22-30 | 3-5 ×10−9 | ||
pregnancy, weeks 32-37 | 6-11 ×10−9 | ||
pregnancy, weeks 38-41 | 25-170 ×10−9 | ||
Estrogen | male | 4-11.5 ×10−11 | |
female, prepubertal | <4 ×10−11 | ||
female, 1–10 days | 6.1-39.4 ×10−11 | ||
female, 11–20 days | 12.2-43.7 ×10−11 | ||
female, 21–30 days | 15.6-35 ×10−11 | ||
female, postmenopausal | <4 ×10−11 | ||
Estrone (E1) | male | 2.9-17 ×10−11 | |
female, follicular | 2-15 ×10−11 | ||
female, 1–10 days of cycle | 4.3-18 ×10−11 | ||
female, 11–20 days of cycle | 7.5-19.6 ×10−11 | ||
female, 20–29 days of cycle | 13.1-20.1 ×10−11 | ||
pregnancy, weeks 22-30 | 3-5 ×10−9 | ||
pregnancy, weeks 32-37 | 5-6 ×10−9 | ||
pregnancy, weeks 38-41 | 7-10 ×10−9 | ||
Ethanol | social high | 0.5 ×10−3 | |
reduced coordination | 0.8 ×10−3 | ||
depression of CNS | >1 ×10−3 | ||
confusion, falling down | 2.0 ×10−3 | ||
loss of consciousness | 3.0 ×10−3 | ||
coma, death | >4 ×10−3 | ||
Fatty acids | nonesterified (free) | 8-25 ×10−5 | |
esterified | 2.5-3.9 ×10−3 | 7-20 ×10−5 | |
total | 1.9-4.5 ×10−3 | ||
Ferritin | male | 1.5-30 ×10−8 | |
female | 0.9-18 ×10−8 | ||
alpha-1-Fetoprotein | 0-2 ×10−8 | ||
Flavin adenine dinucleotide | 8-12 ×10−8 | ||
Fluoride | 1-4.5 ×10−7 | 1-4.5 ×10−7 | |
Folate | 2.2-17.3 ×10−9 | ||
in erythrocyte | 1.67-7.07 ×10−7 | ||
Folic acid | 2.3-5.2 ×10−8 | 1.6-2 ×10−8 | |
Fructose | 0-5 ×10−5 | 7-8 ×10−5 | |
Furosemide glucuronide | 1-400 ×10−6 | ||
Galactose | children | <2 ×10−4 | |
Gastric inhibitory peptide (GIP) | <1.25-4.0 ×10−10 | ||
Gastrin | mean | 7 ×10−11 | |
maximum | <20 ×10−11 | ||
Globulin | total 2.2-4 ×10−2 | ||
alpha-1-Globulin | 1-4 ×10−3 | ||
alpha-2-Globulin | 4-10 ×10−3 | ||
beta globulin | 5-12 ×10−3 | ||
gamma globulin | 6-17 ×10−3 | ||
Glucagon | range | 5-15 ×10−11 | |
mean | 7.1-7.9 ×10−11 | ||
Glucosamine | fetus | 4-6 ×10−4 | 4.2-5.5 ×10−4 |
child | 5-7 ×10−4 | 5.2-6.9 ×10−4 | |
adult | 6-8 ×10−4 | 6.1-8.2 ×10−4 | |
aged | 7-9 ×10−4 | 7.0-8.9 ×10−4 | |
Glucose | newborn | 2-3 ×10−4 | |
adult | 6.5-9.5 ×10−4 | 7-10.5 ×10−4 | |
diabetic | 14-120 ×10−4 | ||
Glucuronic acid | 4.1-9.3 ×10−5 | 8-11 ×10−6 | |
Glutamic acid | 2-28 ×10−6 | ||
Glutamine | 4.6-10.6 ×10−5 | ||
Glutathione | reduced | 2.5-4.1 ×10−4 | 0 |
Glycerol | free | 2.9-17.2 ×10−6 [2] | |
Glycine | 1.7-2.3 ×10−5 | 8-54 ×10−6 | |
Glycogen | 1.2-16.2 ×10−5 | 0 | |
Glycoprotein, acid | 4-15 ×10−4 | ||
cGMP | 0.6-4.4 ×10−9 | ||
Gonadotropin-releasing hormone | 1-80 ×10−12 | ||
Guanidine | 1.8-2.3 ×10−6 | ||
Haptoglobin | 3-22 ×10−4 | ||
Hemoglobin | 1.2-1.75 ×10−1 | 1-4 ×10−5 | |
newborn | 1.65-1.95 ×10−1 | ||
children, varies with age | 1.12-1.65 ×10−1 | ||
adult, male | 1.4-1.8 ×10−1 | ||
adult, female | 1.2-1.6 ×10−1 | ||
inside erythrocyte | ~3.3 ×10−1 | ||
per red blood cell | 27-32 picograms | ||
Hexosephosphate P | 1.4-5 ×10−5 | 0-2 ×10−6 | |
Histamine | 6.7-8.6 ×10−8 | ||
Histidine | 9-17 ×10−6 | 1.1-3.8 ×10−5 | |
Hydrogen ion(pH 7.4) | 4 ×10−11 | ||
beta-Hydroxybutyric acid | 1-6 ×10−6 | 1-9 ×10−6 | |
17α-Hydroxycorticosteroids | 4-10 ×10−8 | ||
17α-Hydroxyprogesterone | male | 20-250 ×10−11 | |
female, follicular | 20-80 ×10−11 | ||
female, luteal | 80-300 ×10−11 | ||
female, postmenopausal | 4-50 ×10−11 | ||
female, child | 20-140 ×10−11 | ||
Antibodies | Immunoglobulin A (IgA) | 5-39 ×10−4 | |
Immunoglobulin D (IgD) | 0.5-8.0 ×10−5 | ||
Immunoglobulin G (IgG) | 5.0-19 ×10−3 | ||
Immunoglobulin M (IgM) | 3.0-30 ×10−4 | ||
Immunoglobulin E (IgE) | <5 ×10−7 | ||
Indican | 8-50 ×10−7 | ||
Inositol | 3-7 ×10−6 | ||
Insulin | 2.0-8.4 ×10−10 | ||
Insulin-like growth factor | 9.9-50 ×10−8 | ||
Iodine | total | 2.4-3.2 ×10−8 | 4.5-14.5 ×10−8 |
Iron | adult | 4-6 ×10−4 | 6-18 ×10−7 |
Isoleucine | 9-15 ×10−6 | 1.2-4.2 ×10−5 | |
Ketone bodies | 2.3-10 ×10−6 | 1.5-30 ×10−6 | |
alpha-Ketonic acids | adult | 1-30 ×10−6 | |
L-Lactate | arterial | <11.3 ×10−5 | 4.5-14.4 ×10−5 |
venous | 8.1-15.3 ×10−5 | 4.5-19.8 ×10−5 | |
Lead | normal | 1-5 ×10−7 | 1-7.8 ×10−8 |
toxic | >6-10 ×10−7 | ||
Lecithin | 1.1-1.2 ×10−3 | 1-2.25 ×10−3 | |
Leptin | 1.2 ×10−8 | ||
Leucine | 1.4-2 ×10−5 | 1.2-5.2 ×10−5 | |
Leukocytes (#/cm3) Total: | total, birth | 9.0-30.0 ×106 | |
total, pediatric | 4.5-15.5 ×106 | ||
total, adult, range | 4.3-11.0 ×106 | ||
total, adult, median | 7.0 ×106 | ||
Neutrophil granulocytes, birth | 6.0-26.0 ×106 | ||
Neutrophils, pediatric | 1.5-8.5 ×106 | ||
Neutrophils, adult, range | 1.83-7.25 ×106 | ||
Neutrophils, adult, median | 3.65 ×106 | ||
Eosinophil granulocytes birth | 0.4 ×106 | ||
Eosinophils, pediatric | 0.2-0.3 ×106 | ||
Eosinophils, adult, range | 0.05-0.7 ×106 | ||
Eosinophils, adult, median | 0.15 ×106 | ||
Basophil granulocytes, adult, range | 0.015-0.15 ×106 | ||
Basophils, adult, median | 0.03 ×106 | ||
Lymphocytes, birth | 2-11 ×106 | ||
Lymphocyte, pediatric | 1.5-8.0 ×106 | ||
Lymphocyte, adult, range | 1.5-4.0 ×106 | ||
Lymphocyte, adult, median | 2.5 ×106 | ||
Monocytes, birth, range | 0.4-3.1 ×106 | ||
Monocytes, birth, median | 1.05 ×106 | ||
Monocytes, pediatric | 0.4 ×106 | ||
Monocytes, adult, range | 0.21-1.05 ×106 | ||
Monocytes, adult, median | 0.43 ×106 | ||
Phagocytes, birth, range | 6-26 ×106 | ||
Phagocytes, birth, median | 11 ×106 | ||
Phagocytes, pediatric, range | 1.5-8.5 ×106 | ||
Phagocytes, pediatric, median | 4.1 ×106 | ||
Phagocytes, adult, range | 3.5-9.2 ×106 | ||
Phagocytes, CD4 cell count | 0.5-1.5 ×106 | ||
Lipase P | 1.2-1.4 ×10−4 | ||
Lipids | total | 4.45-6.1 ×10−3 | 4-8.5 ×10−3 |
Lipoprotein (Sr 12-20) | 1-10 ×10−4 | ||
Lithium | 1.5-2.5 ×10−8 | ||
Lysine | 1.3-3 ×10−5 | 2-5.8 ×10−5 | |
Lysozyme (muramidase) | 1-15 ×10−6 | ||
alpha 2-macroglobulin | pediatric | 2-7 ×10−3 | |
male, adult | 0.9-4.0 ×10−3 | ||
female, adult | 1.2-5.4 ×10−3 | ||
Magnesium | 3.2-5.5 ×10−5 | 1.8-3.6 ×10−5 | |
Malic acid | 4.6 ×10−6 | 1-9 ×10−6 | |
Manganese | 0-2.5 ×10−7 | 0-1.9 ×10−7 | |
Melatonin | Day | 1.35-1.45 ×10−11 | |
Night | 6.07-7.13 ×10−11 | ||
Mercury | normal | <1 ×10−8 | |
chronic | >20 ×10−8 | ||
Methemoglobin | 4-6 ×10−4 | ||
Methionine | 4-6 ×10−6 | 1-15 ×10−6 | |
Methyl guanidine | 2-3 ×10−6 | ||
beta-2-microglobulin | 8-24 ×10−7 | ||
MIP-1a | 2.3 ×10−11 | ||
MIP-1b | 9 ×10−11 | ||
Mucopolysaccharides | 1.75-2.25 ×10−3 | ||
Mucoproteins | 8.65-9.6 ×10−4 | ||
Nerve growth factor (NGF) | 6-10 ×10−9 | ||
Niacin | 5-8 ×10−6 | 2-15 ×10−7 | |
Nitrogen | respiratory gas | 8.2 ×10−6 | 9.7 ×10−6 |
total, nonrespiratory | 3-3.7 ×10−2 | ||
Norepinephrine | Neurotransmitter of the sympathetic nervous system | ||
after 15 min rest | 2.15-4.75 ×10−10 | ||
when emitted | 8.1 ×10−9 | 8.5 ×10−9 | |
Nucleotide | total | 3.1-5.2 ×10−4 | |
Ornithine | 4-14 ×10−6 | ||
Oxalate | 1-2.4 ×10−6 | ||
Oxygen (respiratory gas) | arterial | 2.4-3.2 ×10−4 | 3.9 ×10−6 |
venous | 1.6-2.3 ×10−4 | 1.6 ×10−6 | |
Oxytocin | male | 2 ×10−12 | |
female, nonlactating | 2 ×10−12 | ||
female, pregnant 33-40 wks | 32-48 ×10−12 | ||
Pancreatic polypeptide | 5-20 ×10−11 | ||
Pantothenic acid (vitamin B5) | 1.5-4.5 ×10−7 | 6-35 ×10−8 | |
Para-aminobenzoic acid | 3-4 ×10−8 | ||
Parathyroid hormone (PTH) | 2-4 ×10−10 | ||
Pentose | phosphorated | 2-2.3 ×10−5 | |
Phenol | free | 7-10 ×10−7 | |
Phenylalanine | 8-12 ×10−6 | 1.1-4 ×10−5 | |
Phospholipid | 2.25-2.85 ×10−3 | 5-12 ×10−5 | |
Phosphatase | acid, prostatic | <3 ×10−9 | |
Phosphorus | inorganic, adult | 2-3.9 ×10−5 | 2.3-4.5 ×10−5 |
inorganic, children | 4.0-7.0 ×10−5 | ||
total | 3.5-4.3 ×10−4 | 1-1.5 ×10−4 | |
Phytanic acid | <3 ×10−6 | ||
Platelets (#/cm3): | range | 1.4-4.4 ×108 | |
median | 2.5 ×108 | ||
Platelet-derived growth factor | 5.0 ×10−8 | ||
Polysaccharides | total | 7.3-13.1 ×10−4 | |
Potassium | 1.6-2.4 ×10−3 | 1.4-2.2 ×10−4 | |
Pregnenolone | 3-20 ×10−10 | ||
Progesterone (female) | female, follicular | 0.4-0.9 ×10−9 | |
female, midluteal | 7.7-12.1 ×10−9 | ||
pregnancy, weeks 16-18 | 30-66 ×10−9 | ||
pregnancy, weeks 28-30 | 70-126 ×10−9 | ||
pregnancy, weeks 38-40 | 131-227 ×10−9 | ||
male | 12-20 ×10−11 | ||
Proinsulin | fasting | 0.5-5 ×10−10 | |
mean | 1.42-1.70 ×10−10 | ||
Prolactin (male) <20 ×10−9 | while awake | 1-7 ×10−9 | |
during sleep | 9-20 ×10−9 | ||
Prolactin (female) | follicular | <23 ×10−9 | |
luteal | 5-40 ×10−9 | ||
Proline | 1.2-5.7 ×10−5 | ||
Prostaglandins | PGE | 3.55-4.15 ×10−10 | |
PGF | 1.26-1.56 ×10−10 | ||
15-keto-PGF2a | 5 ×10−10 | ||
15-keto-PGE2 | <5 ×10−11 | ||
Protein | total | 1.9-2.1 ×10−1 | 6.0-8.3 ×10−2 |
Protoporphyrin | 2.7-6.1 ×10−7 | ||
Prostate specific antigen | 0-5 ×10−9 | ||
Pseudoglobulin I | 8-19 ×10−3 | ||
Pseudoglobulin II | 2-8 ×10−3 | ||
Purine | total | 9.5-11.5 ×10−5 | |
Pyrimidine nucleotides | 2.6-4.6 ×10−5 | 2-12 ×10−7 | |
Pyridoxine (Vitamin B6) | 3.6-90 ×10−9 | ||
Pyruvic acid | 3-10 ×10−6 | 3-12 ×10−6 | |
RANTES | 7 ×10−11 | ||
Relaxin | day <100 preparturition | <2 ×10−9 | |
day 100 to 2 days preceding | 5-40 ×10−9 | ||
day preceding parturition | 100-200 ×10−9 | ||
day following parturition | <2 ×10−9 | ||
Retinol (Vitamin A) | 1-8 ×10−7 | ||
Riboflavin (Vitamin B2) | 1.5-6 ×10−7 | 2.6-3.7 ×10−8 | |
RNA | 5-8 ×10−4 | 4-6 ×10−5 | |
Secretin | 2.9-4.5 ×10−11 | ||
Serine | 3-20 ×10−6 | ||
Serotonin (5-hydroxytryptamine) | 1.55-1.81 ×10−7 | 0.8-2.1 ×10−7 | |
Silicon | 1.4-2.95 ×10−6 | 2.2-5.7 ×10−6 | |
Sodium | 3.1-3.4 ×10−3 | ||
Solids, total | 2-2.5 ×10−1 | 8-9 ×10−2 | |
Somatotropin | growth hormone | 4-140 ×10−10 | |
Sphingomyelin | 1.5-1.85 ×10−3 | 1-4 ×10−4 | |
Succinic acid | 5 ×10−6 | ||
Sugar, total | 7-11 ×10−4 | ||
Sulfates | inorganic | 8-12 ×10−6 | |
Sulfur | total | 3.8-5 ×10−2 | 3.1-3.8 ×10−2 |
Taurine | 3-21 ×10−6 | ||
Testosterone (male) | free | 5.6-10.2 ×10−11 | |
total | 275-875 ×10−11 | ||
Testosterone (female) | free | 0.24-0.38 ×10−11 | |
total | 23-75 ×10−11 | ||
pregnant | 38-190 ×10−11 | ||
Thiamine (Vitamin B1) | 3-10 ×10−8 | 1-9 ×10−8 | |
Thiocyanate | 5-14 ×10−6 | ||
nonsmoker | 1-4 ×10−6 | ||
smoker | 3-12 ×10−6 | ||
Threonine | 1.3-2 ×10−5 | 0.9-3.2 ×10−5 | |
Thyroglobulin (Tg) | <5 ×10−8 | ||
Thyroid hormones | 4-8 ×10−8 | ||
Thyrotropin-releasing hormone | 5-60 ×10−12 | ||
Thyroxine (FT4) | free | 8-24 ×10−12 | |
total | 4-12 ×10−8 | ||
Thyroxine-binding prealbumin | 2.8-3.5 ×10−4 | ||
Thyroxine-binding globulin | 1.0-3.4 ×10−7 | ||
Tin | 0-4 ×10−7 | 0-1 ×10−7 | |
alpha-Tocopherol (Vitamin E) | 5-20 ×10−6 | ||
Transcortin | male | 1.5-2 ×10−5 | |
female | 1.6-2.5 ×10−5 | ||
Transferrin | newborn | 1.3-2.75 ×10−3 | |
adult | 2.2-4 ×10−3 | ||
age >60 yrs | 1.8-3.8 ×10−3 | ||
Triglycerides | 8.5-23.5 ×10−4 | 2.5-30 ×10−4 | |
Triiodothyronine | free | 2.3-6.6 ×10−12 | |
total (T3) | 0.75-2.50 ×10−9 | ||
Tryptophan | 5-10 ×10−6 | 9-30 ×10−6 | |
Tyrosine | 8-14 ×10−6 | 4-25 ×10−6 | |
Urea | 2-4 ×10−4 | 1.5-4.7 ×10−4 [1] | |
Uric acid | child | 2.0-6.7 ×10−5 [3] | |
adult, male | 3.4-7.2 ×10−5 [1] | ||
adult, female | 2.4-6.1 ×10−5 [1] | ||
Valine | 2-2.9 ×10−5 | 1.7-4.2 ×10−5 | |
Vasoactive intestinal peptide (VIP) | 6-16 ×10−12 | ||
Vasopressin | hydrated | 4.5 ×10−13 | |
dehydrated | 3.7 ×10−12 | ||
Zinc | 5-13 ×10−6 | 7-15 ×10−7 |
In blood banking, the fractions of Whole Blood used for transfusion are also called components.
Boyle County is a county located in the central part of Kentucky. As of the 2020 census, the population was 30,614. Its county seat is Danville. The county was formed in 1842 and named for John Boyle (1774–1835), a U.S. Representative, chief justice of the Kentucky Court of Appeals, and later federal judge for the District of Kentucky, and is part of the Danville, KY Micropolitan Statistical Area.
Phlebotomy is the process of making a puncture in a vein, usually in the arm, with a cannula for the purpose of drawing blood. The procedure itself is known as a venipuncture, which is also used for intravenous therapy. A person who performs a phlebotomy is called a phlebotomist, although most doctors, nurses, and other technicians can also carry out a phlebotomy. In contrast, phlebectomy is the removal of a vein.
Middletown is a city located in Butler and Warren counties in the southwestern part of the U.S. state of Ohio, about 35 miles (47 km) north of Cincinnati. The population as of the 2020 census was 50,987. It is part of the Cincinnati metropolitan area.
A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term "blood bank" typically refers to a department of a hospital usually within a Clinical Pathology laboratory where the storage of blood product occurs and where pre-transfusion and Blood compatibility testing is performed. However, it sometimes refers to a collection center, and some hospitals also perform collection. Blood banking includes tasks related to blood collection, processing, testing, separation, and storage.
The hematocrit, also known by several other names, is the volume percentage (vol%) of red blood cells (RBCs) in blood, measured as part of a blood test. The measurement depends on the number and size of red blood cells. It is normally 40.7–50.3% for males and 36.1–44.3% for females. It is a part of a person's complete blood count results, along with hemoglobin concentration, white blood cell count and platelet count.
Uranium-235 is an isotope of uranium making up about 0.72% of natural uranium. Unlike the predominant isotope uranium-238, it is fissile, i.e., it can sustain a nuclear chain reaction. It is the only fissile isotope that exists in nature as a primordial nuclide.
The prothrombin time (PT) – along with its derived measures of prothrombin ratio (PR) and international normalized ratio (INR) – is an assay for evaluating the extrinsic pathway and common pathway of coagulation. This blood test is also called protime INR and PT/INR. They are used to determine the clotting tendency of blood, in such things as the measure of warfarin dosage, liver damage, and vitamin K status. PT measures the following coagulation factors: I (fibrinogen), II (prothrombin), V (proaccelerin), VII (proconvertin), and X.
Toivakka is a municipality of Finland. It is located in the Central Finland region, near Jyväskylä. The municipality has a population of 2,386 (31 December 2021) and covers an area of 413.94 square kilometres (159.82 sq mi) of which 52.44 km2 (20.25 sq mi) is water. The population density is 6.6 inhabitants per square kilometre (17/sq mi). The municipality is unilingually Finnish.
A granitoid is a generic term for a diverse category of coarse-grained igneous rocks that consist predominantly of quartz, plagioclase, and alkali feldspar. Granitoids range from plagioclase-rich tonalites to alkali-rich syenites and from quartz-poor monzonites to quartz-rich quartzolites. As only two of the three defining mineral groups need to be present for the rock to be called a granitoid, foid-bearing rocks, which predominantly contain feldspars but no quartz, are also granitoids. The terms granite and granitic rock are often used interchangeably for granitoids; however, granite is just one particular type of granitoid.
Montauk Air Force Station was a US military base at Montauk Point on the eastern tip of Long Island, New York. It was decommissioned in 1981 and is now owned by the New York State Office of Parks, Recreation and Historic Preservation as Camp Hero State Park.
Miyazaki Station is a JR Kyushu railway station located in Miyazaki, Miyazaki Prefecture, Japan. The central station of the prefectural capital is served by the Nippō Main Line connecting Fukuoka Prefecture and Kagoshima Prefecture. The station opened on December 15, 1913.
Zinc finger protein 238 is a zinc finger containing transcription factor that in humans is encoded by the ZNF238 gene.
National Route 236 is a national highway connecting Obihiro, Hokkaido and Urakawa, Hokkaido in Japan.
Kallithea, is a village and a community in the municipal unit of Alykes in the island of Zakynthos, Greece. In 2011 Kallithea's population was 238 people. It is situated at the eastern foot of the Vrachionas mountains, at about 60 m (200 ft) elevation. It is 3 km (1.9 mi) southeast of Katastari, 3 km (1.9 mi) southwest of Ano Gerakari, 3 km (1.9 mi) northwest of Agios Dimitrios and 12 km (7.5 mi) northwest of Zakynthos city. The farm of the Science Park Zakynthos, a Norwegian-Greek institute that focuses on sustainable water use, is situated in Kallithea. The village suffered great damage from the 1953 Ionian earthquake.
Wyoming Highway 238 is a 12.08-mile-long (19.44 km) Wyoming state road located in north-central Lincoln County, Wyoming.
The 16th Guards Fighter Aviation Division was an Aviation Division of the Soviet Air Forces, active from 1942 to 1998. Originally activated in 1942 as the 258th Fighter Aviation Division from the Air Forces of the 14th Army, then the 258th Mixed Aviation Division 27.2.43; redesignated in accordance with NKO Decree No. 264 as the 1st Guards Composite Aviation Division от 24.08.43; redesignated 16th Guards Fighter Aviation Division 11 November 1944.
Cold sensitive antibodies (CSA) are antibodies sensitive to cold temperature. Some cold sensitive antibodies are pathological and can lead to blood disorder. These pathological cold sensitive antibodies include cold agglutinins, Donath–Landsteiner antibodies, and cryoglobulins which are the culprits of cold agglutinin disease, paroxysmal cold hemoglobinuria in the process of Donath–Landsteiner hemolytic anemia, and vasculitis, respectively.
Rani Khera is a village in Sareni block of Rae Bareli district, Uttar Pradesh, India. It is located 27 km from Lalganj, the tehsil headquarters. As of 2011, it has a population of 1,451 people, in 278 households. It has one primary school and no healthcare facilities. It belongs to the nyaya panchayat of Murarmau.
The fibrinopeptides, fibrinopeptide A (FpA) and fibrinopeptide B (FpB), are peptides which are located in the central region of the fibrous glycoprotein fibrinogen and are cleaved by the enzyme thrombin to convert fibrinogen into covalently-linked fibrin monomers. The N-terminal FpA is cleaved from the Aα chains of fibrinogen and FpB from the Bβ chains of fibrinogen, with FpA released before FpB. Subsequent to their formation, fibrin monomers are converted to cross-linked fibrin polymers by the action of thrombin-activated factor XIII, and these fibrin polymers form the backbone of a thrombus. Hence, the fibrinopeptides are sensitive markers of fibrinogenesis, thrombin activity, and coagulation.